首页> 外文期刊>Saudi Pharmaceutical Journal >Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques
【24h】

Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques

机译:使用通过不同技术制备的固体分散体改善生物活性芹菜素的溶解度和生物利用度

获取原文
获取外文期刊封面目录资料

摘要

Apigenin (APG) is a poorly soluble bioactive compoundutraceutical which shows poor bioavailability upon oral administration. Hence, the objective of this research work was to develop APG solid dispersions (SDs) using different techniques with the expectation to obtain improvement in its in vitro dissolution rate and in vivo bioavailability upon oral administration. Different SDs of APG were prepared by microwave, melted and kneaded technology using pluronic-F127 (PL) as a carrier. Prepared SDs were characterized using “thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), Fourier transform infra-red (FTIR) spectrometer, powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM)”. After characterization, prepared SDs of APG were studied for in vitro drug release/dissolution profile and in vivo pharmacokinetic studies. The results of TGA, DSC, FTIR, PXRD and SEM indicated successful formation of APG SDs. In vitro dissolution experiments suggested significant release of APG from all SDs (67.39–84.13%) in comparison with control (32.74%). Optimized SD of APG from each technology was subjected to in vivo pharmacokinetic study in rats. The results indicated significant improvement in oral absorption of APG from SD prepared using microwave and melted technology in comparison with pure drug and commercial capsule. The enhancement in oral bioavailability of APG from microwave SD (319.19%) was 3.19 fold as compared with marketed capsule (100.00%). Significant enhancement in the dissolution rate and oral absorption of APG from SD suggested that developed SD systems can be successfully used for oral drug delivery system of APG.
机译:芹菜素(APG)是一种难溶的生物活性化合物/营养素,口服给药时显示出不良的生物利用度。因此,这项研究工作的目的是使用不同的技术来开发APG固体分散体(SD),以期在口服时获得其体外溶出度和体内生物利用度的改善。使用pluronic-F127(PL)作为载体,通过微波,熔融和捏合技术制备了APG的不同SD。使用“热重分析(TGA),差示扫描量热法(DSC),傅立叶变换红外(FTIR)光谱仪,粉末X射线衍射(PXRD)和扫描电子显微镜(SEM)”对制备的SD进行表征。表征后,对制备的APG SD进行体外药物释放/溶解特性和体内药代动力学研究。 TGA,DSC,FTIR,PXRD和SEM的结果表明成功形成了APG SD。体外溶出实验表明,与对照组(32.74%)相比,所有标清液均显着释放了APG(67.39–84.13%)。对来自每种技术的APG的优化SD进行了大鼠体内药代动力学研究。结果表明,与纯药物和市售胶囊相比,微波和熔融技术制备的SD口服APG的吸收显着改善。与市售胶囊剂(100.00%)相比,微波SD的APG口服生物利用度提高(319.19%)是3.19倍。 SD的APG的溶出度和口服吸收的显着提高表明,开发的SD系统可以成功用于APG的口服药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号